Last edition
News about Global Pharma
Suanfarma Appoints Mane Godina as its New CEO
Suanfarma has appointed Pere Mañé Godina as its new CEO, ushering in a new phase focused on industrial consolidation, sustainable innovation, and global expansion.
Global Pharma | 22/04/2025 | By Manvi | 225
Jazz Pharmaceuticals Acquires Chimerix for USD 935 Million
Jazz Pharmaceuticals plc has completed its USD 935 million acquisition of Chimerix, Inc., making it a wholly owned subsidiary and strengthening its oncology portfolio with the addition of the novel drug candidate Dordaviprone.
Global Pharma | 22/04/2025 | By Manvi | 224
BD Launches AI-Powered Hemodynamic Monitoring Platform to Enhance Patient Safety During Procedures
BD (Becton, Dickinson and Company) has launched a new advanced hemodynamic monitoring platform with predictive, artificial intelligence (AI) based algorithms that can help clinicians proactively address blood pressure instability and optimize blood flow to help avoid potential life-threatening situations during procedures.
Global Pharma | 22/04/2025 | By Manvi | 240
ARUP Laboratories now provides a blood test for phosphorylated tau 217 (pTau 217) to assist in identifying whether cognitive decline symptoms in patients ages 60 years and older are related to Alzheimer's disease (AD) pathology.
Global Pharma | 22/04/2025 | By Manvi | 469
Sanoculis Receives CE Mark Approval for MINT Glaucoma Surgery Device in EU
Sanoculis Ltd. announced that it has received CE Mark approval under the Medical Device Regulation (MDR) in the European Union (EU) for its MINT® (Minimally Invasive Nasal Trabeculostomy) product—an innovative, stent-free technology platform for the treatment of adult patients undergoing glaucoma angle surgery.
Global Pharma | 21/04/2025 | By Manvi | 288
FDA Classifies Q'Apel Medical's Recall of 072 Aspiration System as Class I
US Food and Drug Administration, classified Q'Apel Medical, Inc.'s voluntary recall of 1,617 units of its 072 Aspiration System (also known under the product name 'Hippo', which includes 'Cheetah'; collectively, the 'product') as Class I.
Global Pharma | 21/04/2025 | By Manvi | 243
Zydus MedTech Partners with Braile Biomedica to Commercialise TAVI Technology
Zydus MedTech has partnered with Brazil-based Braile Biomedica to exclusively commercialise its advanced Transcatheter Aortic Valve Implantation (TAVI) technology across Europe, India, and select global markets, marking its strategic entry into the interventional cardiology space.
Global Pharma | 21/04/2025 | By Manvi | 499
Alembic Pharmaceuticals Secures USFDA Final Approval for Carbamazepine Tablets
Alembic Pharmaceuticals has received final USFDA approval for its Abbreviated New Drug Application (ANDA) for Carbamazepine Tablets USP, 200 mg, a generic version of Tegretol used as an anticonvulsant and for treating trigeminal neuralgia.
Global Pharma | 21/04/2025 | By Manvi | 257
Lupin Secures EIR from US FDA for its Injectable Facility in Nagpur
Lupin has received the Establishment Inspection Report (EIR) from the US FDA for drug-device combination products at its injectable manufacturing facility in Nagpur, India.
Global Pharma | 21/04/2025 | By Manvi | 1150
RND Automation Acquires QuickPouch's Intellectual Property and Asset
With this acquisition, RND plans to improve the QuickPouch product line and integrate it into their renowned packaging solutions, including the MiniPack, MicroPack, and Kanga Poucher.
Global Pharma | 19/04/2025 | By Manvi | 330
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy